Europe Bioresorbable Polymers Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type [Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polydioxanone, Polycaprolactone (PCL), and Others] and Application (Orthopedic Devices, Drug Delivery, a

Europe Bioresorbable Polymers Market Forecast to 2028 - COVID-19 Impact and Regional Analysis By Type [Polylactic Acid (PLA), Polyglycolic Acid (PGA), Polydioxanone, Polycaprolactone (PCL), and Others] and Application (Orthopedic Devices, Drug Delivery, and Others)

The bioresorbable polymers market in Europe is expected to grow from US$ 996.36 million in 2021 to US$ 1,860.37 million by 2028; it is estimated to grow at a CAGR of 9.3% from 2021 to 2028.

The increasing application of bioresorbable polymers to create organ-like structures using 3D scaffold printing for tissue engineering is gaining significant traction in the healthcare sector. Bioresorbable polymers contain excellent cell adhesion properties that make them suitable for tissue engineering applications, such as bone, tendon, cartilage, tooth, and spinal regeneration. These polymers are fabricated into scaffolds using various techniques, including electrospinning and polymers printing, to create microstructures and nanomaterials that facilitate tissue development. 3D scaffold printing can produce highly complex designs with controllable features for efficient and smooth tissue engineering. The application of bioresorbable polymers for 3D scaffold printing is expected to emerge as the future trend in tissue regenerating treatment and in this market during the forecast period.

In Europe, the UK and Russia are the hardest-hit countries by the COVID-19 pandemic, followed by France, Spain, Italy, and Germany. In the initial phases of the pandemic, European countries implemented drastic measures and travel restrictions, including the shutdown of manufacturing units and limitations on logistics. The consequent disruptions in supply chains and difficulties in raw material procurement have restrained the European market. Although there have been delays in medical surgeries in countries across Europe, elective surgeries resumed in mid-2020 in the UK and many other countries. However, most hospitals are functioning at substantially reduced capacity, resulting in lengthy waitlists. Such delays in medical surgeries have led to decreased demand for medical and orthopedic devices, eventually restricting the bioresorbable polymer market growth in the region.

With the new features and technologies, vendors can attract new customers and expand their footprints in emerging markets. This factor is likely to drive the Europe bioresorbable polymers market at a good CAGR during the forecast period.

Europe Bioresorbable Polymers Market Revenue and Forecast to 2028 (US$ Million)

Europe Bioresorbable Polymers Market Segmentation

Europe Bioresorbable Polymers Market - by Type

Polylactic Acid (Pla) Polyglycolic Acid (Pga) Polydioxanone Polycaprolactone(Pcl) Others Europe Bioresorbable Polymers Market - by Application

Orthopedic Devices Drug Delivery Other Application Europe Bioresorbable Polymers Market - by Country

Germany France Italy UK Russia Rest of Europe Europe Bioresorbable Polymers Market - Companies Mentioned

Evonik Industries AG Musashino Chemical Laboratory, Ltd. Ashland Global Holdings Inc. Poly-Med Incorporated Foster Corporation REVA Medical, LLC Polysciences Inc.

Reasons to Buy

Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the Europe bioresorbable polymers market.
Highlights key business priorities in order to assist companies to realign their business strategies
The key findings and recommendations highlight crucial progressive industry trends in the Europe bioresorbable polymers market, thereby allowing players across the value chain to develop effective long-term strategies
Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
Scrutinize in-depth Europe market trends and outlook coupled with the factors driving the bioresorbable polymers market, as well as those hindering it
Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing, and distribution